Intermittent high permeability hemofiltration in septic patients with acute renal failure

Intensive Care Medicine

Volumn 29, Issue 11, 2003, Pages 1989-1995

  Morgera, Stanislao ^a   Rocktäschel, Jens ^a   Haase, Michael ^a   Lehmann, Christian ^a   Von Heymann, Christian ^a   Ziemer, Sabine ^a   Priem, Friedrich ^a   Hocher, Berthold ^a   Göhl, Hermann ^b   Kox, Wolfgang J ^a   Buder, Hans W ^a   Neumayer, Hans H ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Gambro Dialysatoren GmbH and Co KG   (Germany)

Author keywords

Coagulation factors; Interleukin 6 and tumor necrosis factor clearance rates; Intermittent high permeability hemofiltration; Septic multiple organ failure; Transmembrane protein loss

Indexed keywords

INTERLEUKIN 6; MEMBRANE PROTEIN; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HEMOFILTRATION; HUMAN; MALE; MEMBRANE PERMEABILITY; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDY; PROTEIN DEPLETION; SEPSIS; SEPTIC SHOCK; UNIVERSITY HOSPITAL;

AGED; ANTITHROMBIN III; AREA UNDER CURVE; BLOOD PROTEINS; FEMALE; HEMODYNAMIC PROCESSES; HEMOFILTRATION; HUMANS; INTERLEUKIN-6; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PILOT PROJECTS; PROSPECTIVE STUDIES; PROTEIN C; PROTHROMBIN; REGRESSION ANALYSIS; RISK FACTORS; SAFETY; SERUM ALBUMIN; SHOCK, SEPTIC; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 10744233127     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-2003-9     Document Type: Article

References (21)

1. Barton R, Cerra FB (1989) The hypermetabolism multiple organ failure syndrome. Chest 96:1153-1161
2. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E (1993) Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103:565-575
3. Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, Strauer BE, Grabensee B (1997) Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 23:288-296
4. Bellomo R, Ronco C (2001) Blood purification in the intensive care unit: evolving concepts. World J Surg 25:677-668
5. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH (1999) Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 10:846-853
6. Silvester W (1997) Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis 30:38-43
7. Goldfarb S, Golper T (1994) Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 5:228-232
8. Lonnemann G, Bechstein M, Linnenweber S, Burg M, Koch KM (1999) Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int 56:84-87
9. Van Deuren M, van der Meer JW (2000) Hemofiltration in septic patients is not able to alter the plasma concentration of cytokines therapeutically. Intensive Care Med 26:1176-1178
10. Sanchez-Izquierdo JA, Perez Vela JL, Lozano Quintana MJ, Alted Lopez E, Ortuno de Solo B, Ambros Checa A (1997) Cytokines clearance during venovenous hemofiltration in the trauma patient. Am J Kidney Dis 30:483-488
11. Hoffmann JN, Faist E (2001) Removal of mediators by continuous hemofiltration in septic patients. World J Surg 25:651-659
12. Lee PA, Weger GW, Pryor RW, Matson JR (1998) Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 26:730-737
13. Knaus WA, Draper EA, Wagner DP, Zimmermann JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-829
14. Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S (1999) The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis-related Problems of the ESICM. Intensive Care Med 25:686-696
15. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine. Chest 101:1644-1655
16. Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D (1996) Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22:1360-1367
17. Hinshaw LB (1996) Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 24:1072-1078
18. Bone RC (1996) Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome. Ann Intern Med 125:680-687
19. Bone RC, Grodzin CJ, Balk RA (1997) Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235-243
20. Uchino S, Bellomo R, Goldsmith D, Davenport P, Cole L, Baldwin I, Panagiotopoulos S, Tipping P (2002) Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med 28:651-655
21. Uchino S, Bellomo R, Morimatsu H, Goldsmith D, Davenport P, Cole L, Baldwin I, Panagiotopoulos S, Tipping P, Morgera S, Neumayer HH, Goehl H (2002) Cytokine dialysis: an ex vivo study. ASAIO J 48:650-653